PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
Yan-Pei Zhang(Henan Agricultural University), Zhong‐Yi Dong(Nanfang Hospital), Yuan Fang(Nanfang Hospital), Zhong Wu(Nanfang Hospital), Zi-Xuan Rong(Nanfang Hospital), Xue Bai(Southern Medical University), Jia-Le Tan(Nanfang Hospital), Qiankun Xie(Nanfang Hospital), Duan-Duan Han(Nanfang Hospital), Kexin Zhuang(Nanfang Hospital), Ze-Qin Guo(Nanfang Hospital), Lushan Xiao(Nanfang Hospital), Zipeng Xu(Nanfang Hospital), Min Ruan(Chinese Academy of Medical Sciences & Peking Union Medical College), Si-Cong Ma(Nanfang Hospital), Xiao-Ting Cai(Nanfang Hospital), Wei Wei(Guangxi Medical University), Jian Wang(Nanfang Hospital), Li Liu(Qatar Airways (Qatar)), Jiaqi Chen(Zhejiang Chinese Medical University), Jianying Gu(Fudan University), Jian Guan(Jiamusi University), Yan Lin(Guangdong Medical College), Di Wu(Army Medical University), Dayong Zheng(North China University of Science and Technology), Yue Chen(Nanfang Hospital), Zihang Yu(Nanfang Hospital), Yuanyuan Wang(Hebei Medical University), Chuanhui Cao(Nanfang Hospital), Yu Ruan(Nanfang Hospital), Yang-Si Li(Guangdong Academy of Medical Sciences), Le-Yi Lin(Nanfang Hospital), Xin-Ran Tang(Nanfang Hospital)
Cited by 30
Related Papers
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
|Nature Communications|2019|243
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|225